JP2024533504A5 - - Google Patents

Info

Publication number
JP2024533504A5
JP2024533504A5 JP2024516479A JP2024516479A JP2024533504A5 JP 2024533504 A5 JP2024533504 A5 JP 2024533504A5 JP 2024516479 A JP2024516479 A JP 2024516479A JP 2024516479 A JP2024516479 A JP 2024516479A JP 2024533504 A5 JP2024533504 A5 JP 2024533504A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
cartilage
peg
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533504A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/043391 external-priority patent/WO2023039298A1/en
Publication of JP2024533504A publication Critical patent/JP2024533504A/ja
Publication of JP2024533504A5 publication Critical patent/JP2024533504A5/ja
Pending legal-status Critical Current

Links

JP2024516479A 2021-09-13 2022-09-13 傷害に続く軟骨の再生および再成長のための方法における使用のための組成物 Pending JP2024533504A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163243638P 2021-09-13 2021-09-13
US63/243,638 2021-09-13
PCT/US2022/043391 WO2023039298A1 (en) 2021-09-13 2022-09-13 Composition for use in a method for cartilage regeneration and regrowth following injury

Publications (2)

Publication Number Publication Date
JP2024533504A JP2024533504A (ja) 2024-09-12
JP2024533504A5 true JP2024533504A5 (https=) 2025-09-19

Family

ID=83598402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516479A Pending JP2024533504A (ja) 2021-09-13 2022-09-13 傷害に続く軟骨の再生および再成長のための方法における使用のための組成物

Country Status (10)

Country Link
US (1) US20250144027A1 (https=)
EP (1) EP4401737A1 (https=)
JP (1) JP2024533504A (https=)
KR (1) KR20240058916A (https=)
CN (1) CN118215482A (https=)
AU (1) AU2022342141A1 (https=)
CA (1) CA3231658A1 (https=)
IL (1) IL311412A (https=)
MX (1) MX2024003105A (https=)
WO (1) WO2023039298A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023365200A1 (en) 2022-10-18 2025-05-15 Eluciderm Inc. 2-substituted 3,4 a, 5, 7, 8, 8 a-hexahydro-4h-thiop yrano [4,3- d]pyrimidin-4-ones for wound treatment
WO2025194162A1 (en) * 2024-03-15 2025-09-18 Eluciderm Inc. Pharmaceutical compositions of wnt pathway inhibitors for wound treatment
CN118767170A (zh) * 2024-06-24 2024-10-15 安徽中医药大学 一种应力响应青藤碱缓释纳米药物及制备方法和应用
WO2026006460A2 (en) 2024-06-25 2026-01-02 Eluciderm Inc. Methods of preparing a conjugate of graphene-oxide and hyaluronic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
CA3092171C (en) * 2017-10-06 2025-04-01 Eluciderm Inc. COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS

Similar Documents

Publication Publication Date Title
JP2024533504A5 (https=)
US20220016246A1 (en) Hypertonic antimicrobial therapeutic compositions
JP2025142338A5 (https=)
TWI556838B (zh) 治療關節炎之方法
US10568966B2 (en) Formulation for topical wound treatment
EP2249805B1 (en) Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol
JP3597333B2 (ja) 急性鼻炎を処置するための医薬製剤
UA79075C2 (uk) Фармацевтична композиція, що містить гіалуронову кислоту та гліцерритинову кислоту, та її застосування
PL209943B1 (pl) Zastosowanie moksifloksacyny stanowiącej kwas 1-cyklopropylo-6-fluoro-1,4-dihydro-8-metoksy-7-[(4aS,7aS)-oktahydro-6H-pirolo [3,4-b]pirydyn-6-ylo]-4-okso-3-chinolino-karboksylowy
WO2019155389A1 (en) An aqueous mucoadhesive and bioadhesive composition for the treatment
CN101641103B (zh) 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途
JP4712380B2 (ja) 外用剤
JPS61282320A (ja) 鼻腔用医薬組成物
WO2007133261A1 (en) Mucosal formulation
CA2152398A1 (en) Hyaluronic acid-urea pharmaceutical compositions and uses
RU2655808C2 (ru) Фармацевтическая комбинированная композиция для местного и наружного применения на основе бактериолитического и протеолитического комплекса ферментов
JPH10158169A (ja) 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法
JP2017501227A (ja) アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法
JP5383695B2 (ja) ブラジキニン拮抗薬およびヒアルロン酸を含む医薬組成物、およびその使用
JP2002534477A5 (https=)
JP2002534477A (ja) メラガトランの新規使用
CN1845746A (zh) 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂
US8236814B2 (en) Composition and method for treatment of warts
JP2000507207A (ja) 複合注射剤
BE1018740A3 (nl) Samenstelling voor de behandeling van vochtige epitheliale oppervlakken.